Twist Bioscience stock pulls back as overbought signals grow despite positive mutation mapping project

Traders Union
All News
Business & Wealth
Companies
Twist Bioscience drops 3.75% today

Highlights

TWST maintains a strong bullish structure across all timeframes, trading significantly above key moving averages.
Technical signals show robust buying momentum, but multiple indicators flag overbought conditions and rising risk of short-term pullback.
Expected range for the coming week is $94.50–$103.75; a breakout above $104.69 targets new highs, while support remains firm above $94.50.

The team examined recent variants and epistatic hotspot residues. PLOS Pathogens published the work.

View post on X Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Bullish structure sustained as key supports hold above long-term averages

TWST is trading substantially above its SMA-20 ($83.56), SMA-50 ($68.89), and SMA-200 ($45.98), underscoring a firmly bullish structure across short, medium, and long-term timeframes. The Ichimoku Kijun level on D1 is at $82.45, which is well below the current price and thus acts as immediate support; near-term support is near $83.56 (SMA-20) with key support at $68.89 (SMA-50), while resistance lies at $100.00 (clustered with recent short-term averages) and $104.69 (HMA on D1).

Momentum stays strong despite overbought signals and weekly losses

Momentum signals remain positive, with MACD and ADX on D1 both indicating continuing buying interest. However, multiple oscillators—RSI, Stoch RSI, and CCI—show overbought conditions, suggesting a risk of short-term exhaustion. BBP is in the overbought zone and signals buyer dominance despite some intraday reversals. The Awesome Oscillator on D1 supports the ongoing bullish structure. In today's session, TWST dropped 3.75% and is trading at $98.41, down from the previous weekly close of $99.84. This reflects a 1.28% decline over the past week, with the price hugging the lower part of its weekly range and volatility at 9.75%. The week has thus been characterized by a steady pullback from recent highs.

Upside favored as trend alignment outweighs pullback risks

Looking ahead, the expected trading range for the coming week is $94.50 to $103.75, which is adjusted to fit within the past week's volatility and keeps the price anchored between the strong 52-week low ($23.30) and high ($104.65). Based on the alignment of Buy signals across all major weekly indicators—RSI, ADX, MACD, and MA-50—the probability of another price increase is very high (more than 80%), while the chance of a significant decline is very low. The baseline scenario is continued sideways consolidation within the $95–$104 band. In the bullish case, a breakout above $104.69 could target new yearly highs. In the bearish scenario, a drop below $94.50 would risk deeper correction toward medium-term supports, but strong trend signals on both D1 and W1 make this less likely.

Previously it was reported that Twist Bioscience was exhibiting strong bullish momentum, with technical analysis suggesting further upside potential. As conditions have evolved, traders should now pay close attention to the latest support and resistance shifts to identify any signs of a momentum shift or breakout opportunity.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.